Texas launched a lawsuit against the U.S. Food and Drug Administration last week over the agency’s approval of mifepristone, marking the state’s latest effort to crack down on access to abortion pills.
Joined by Florida, Texas Attorney General Ken Paxton filed the case on Dec. 9 in federal court in Wichita Falls. The two states argued in a 120-page complaint that the FDA did not properly evaluate mifepristone’s safety and effectiveness when approving the drug in 2000 and its subsequent generic versions. They also challenged the agency’s moves that expanded access to the pills, including the ability to dispense them by mail.
Abortion access advocates have blasted the lawsuit.
“If they succeed in restricting access to mifepristone, abortion access will be devastated across the country, even in states where abortion remains legal,” Shellie Hayes-McMahon, executive director of Planned Parenthood Advocates of Texas. “This lawsuit is not about safety or healthcare; it is about control. And nothing short of full control over our bodies will satisfy them.”











